| 000160 (2018) |
Daniil A. Korenkov [Russie] ; Karen L. Laurie [Australie] ; Patrick C. Reading [Australie] ; Louise A. Carolan [Australie] ; Kok Fei Chan [Australie] ; Irina I. Isakova-Sivak [Russie] ; Tatiana A. Smolonogina [Russie] ; Kanta Subbarao [Australie] ; Ian G. Barr [Australie] ; Julie Villanueva [États-Unis] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa G. Rudenko [Russie] | Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model. |
| 000A07 (2012) |
Zhongying Chen ; Helen Zhou ; Lomi Kim ; Hong Jin | The Receptor Binding Specificity of the Live Attenuated Influenza H2 and H6 Vaccine Viruses Contributes to Vaccine Immunogenicity and Protection in Ferrets |
| 000A76 (2012) |
Alexandra S. Gambaryan [Russie] ; Natalia F. Lomakina ; Elizaveta Y. Boravleva ; Ekaterina A. Kropotkina ; Vadim V. Mashin ; Igor V. Krasilnikov ; Alexander I. Klimov ; Larisa G. Rudenko | Comparative safety, immunogenicity, and efficacy of several anti-H5N1 influenza experimental vaccines in a mouse and chicken models (Testing of killed and live H5 vaccine). |
| 000C50 (2011) |
Penghui Yang [République populaire de Chine] ; Yueqiang Duan ; Cheng Wang ; Li Xing ; Xiao Gao ; Chong Tang ; Deyan Luo ; Zhongpeng Zhao ; Weihong Jia ; Daxin Peng ; Xiufan Liu ; Xiliang Wang | Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets. |
| 000C81 (2011) |
Kortney M. Gustin [États-Unis] ; Taronna R. Maines ; Jessica A. Belser ; Neal Van Hoeven ; Xuihua Lu ; Libo Dong ; Irina Isakova-Sivak ; Li-Mei Chen ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Nancy J. Cox ; Terrence M. Tumpey ; Alexander I. Klimov ; Larisa Rudenko ; Ruben O. Donis ; Jacqueline M. Katz | Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets. |
| 000D64 (2011) |
Kortney M. Gustin [Géorgie] ; Taronna R. Maines [Géorgie] ; Jessica A. Belser [Géorgie] ; Neal Van Hoeven [Géorgie] ; XUIHUA LU [Géorgie] ; LIBO DONG [Géorgie] ; Irina Isakova-Sivak [Géorgie, Russie] ; Li-Mei Chen [Géorgie] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Nancy J. Cox [Géorgie] ; Terrence M. Tumpey [Géorgie] ; Alexander I. Klimov [Géorgie] ; Larisa Rudenko [Russie] ; Ruben O. Donis [Géorgie] ; Jacqueline M. Katz [Géorgie] | Comparative Immunogenicity and Cross-Clade Protective Efficacy of Mammalian Cell-Grown Inactivated and Live Attenuated H5N1 Reassortant Vaccines in Ferrets |
| 001096 (2009) |
Xing Cheng [États-Unis] ; Michael Eisenbraun [États-Unis] ; Qi Xu [États-Unis] ; Helen Zhou [États-Unis] ; Deepali Kulkarni [États-Unis] ; Kanta Subbarao [États-Unis] ; George Kemble [États-Unis] ; Hong Jin [États-Unis] | H5N1 Vaccine-Specific B Cell Responses in Ferrets Primed with Live Attenuated Seasonal Influenza Vaccines |
| 001225 (2008) |
Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton Katlinsky | Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials). |
| 000012 (2020) |
Thomas A. Hilimire [États-Unis] ; Aitor Nogales [États-Unis] ; Kevin Chiem [États-Unis] ; Javier Ortego [Espagne] ; Luis Martinez-Sobrido [États-Unis] | Increasing the Safety Profile of the Master Donor Live Attenuated Influenza Vaccine. |
| 000048 (2019) |
Irina Isakova-Sivak [Russie] ; Victoria Matyushenko [Russie] ; Tatiana Kotomina [Russie] ; Irina Kiseleva [Russie] ; Elena Krutikova [Russie] ; Svetlana Donina [Russie] ; Andrey Rekstin [Russie] ; Natalia Larionova [Russie] ; Daria Mezhenskaya [Russie] ; Konstantin Sivak [Russie] ; Arman Muzhikyan [Russie] ; Anastasia Katelnikova [Russie] ; Larisa Rudenko [Russie] | Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge |
| 000142 (2018) |
Larisa Rudenko ; Irina Kiseleva ; Elena Krutikova ; Ekaterina Stepanova ; Irina Isakova-Sivak ; Svetlana Donina ; Andrey Rekstin ; Maria Pisareva ; Ekaterina Bazhenova ; Tatiana Kotomina ; Anastasia Katelnikova ; Arman Muzhikyan ; Valery Makarov ; Erin Grace Sparrow ; Guido Torelli | Two Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets |
| 000297 (2017) |
Andrey Rekstin [Russie] ; Irina Isakova-Sivak [Russie] ; Galina Petukhova [Russie] ; Daniil Korenkov [Russie] ; Igor Losev [Russie] ; Tatiana Smolonogina [Russie] ; Tatiana Tretiak [Russie] ; Svetlana Donina [Russie] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa Rudenko [Russie] | Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein |
| 000449 (2016) |
J Rgen De Jonge [Pays-Bas] ; Irina Isakova-Sivak [Russie] ; Harry Van Dijken [Pays-Bas] ; Sanne Spijkers [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Rineke De Jong [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Paul Roholl [Pays-Bas] ; Larisa Rudenko [Russie] | H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets. |
| 000458 (2016) |
Irina Isakova-Sivak [Russie] ; Daniil Korenkov [Russie] ; Tatiana Smolonogina [Russie] ; Tatiana Tretiak [Russie] ; Svetlana Donina [Russie] ; Andrey Rekstin [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Li-Mei Chen [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa Rudenko [Russie] | Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model |
| 000600 (2015) |
Mariana Baz [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; James Zengel [États-Unis] ; Xing Cheng [États-Unis] ; John J. Treanor [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie] | A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. |
| 000724 (2014) |
Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Xing Cheng [États-Unis] ; Fernando Torres-Velez [États-Unis] ; Marlene Orandle [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | Evaluation of Three Live Attenuated H2 Pandemic Influenza Vaccine Candidates in Mice and Ferrets |
| 000C46 (2011) |
Amorsolo L. Suguitan [États-Unis] ; Xing Cheng [États-Unis] ; Weijia Wang [États-Unis] ; Shixia Wang [États-Unis] ; Hong Jin [États-Unis] ; Shan Lu [États-Unis] | Influenza H5 Hemagglutinin DNA Primes the Antibody Response Elicited by the Live Attenuated Influenza A/Vietnam/1203/2004 Vaccine in Ferrets |
| 000D93 (2010) |
N A Mazurkova ; N N Ryndiuk ; L N Shishkina ; V A Ternovo ; Iu V. Tumanov ; L E Bulychev ; M O Skarnovich ; A S Kabanov ; S G Panchenko ; R P Ale Nikov ; T N Il'Ina ; V I Kuzubov ; S Ia Mel'Nikov ; A N Mironov ; S A Korovkin ; A N Sergeev ; I G Drozdov | [Results of clinical trials on reactogenicity, safety, and immunogenicity of influenza allantoic intranasal live vaccine "Ultragrivac" (type A/H5N2)]. |
| 000E50 (2010) |
Bin Zhou [États-Unis] ; Yan Li [États-Unis, République populaire de Chine] ; Jessica A. Belser ; Melissa B. Pearce ; Mirco Schmolke [États-Unis] ; Anju X. Subba [États-Unis] ; Zhengli Shi [République populaire de Chine] ; Sherif R. Zaki [Géorgie (pays)] ; Dianna M. Blau [Géorgie (pays)] ; Adolfo García-Sastre [États-Unis] ; Terrence M. Tumpey ; David E. Wentworth [États-Unis] | NS-based Live Attenuated H1N1 Pandemic Vaccines Protect Mice and Ferrets |
| 000F07 (2010) |
Ji-Young Min [États-Unis] ; Leatrice Vogel ; Yumiko Matsuoka ; Bin Lu ; David Swayne ; Hong Jin ; George Kemble ; Kanta Subbarao | A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. |
| 000F93 (2010) |
Ji-Young Min [États-Unis] ; Leatrice Vogel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; BIN LU [États-Unis] ; David Swayne [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | A Live Attenuated H7N7 Candidate Vaccine Virus Induces Neutralizing Antibody That Confers Protection from Challenge in Mice, Ferrets, and Monkeys |
| 001030 (2009) |
Amorsolo L. Suguitan ; Michael P. Marino ; Purvi D. Desai ; Li-Mei Chen ; Yumiko Matsuoka ; Ruben O. Donis ; Hong Jin ; David E. Swayne ; George Kemble ; Kanta Subbarao | The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus |
| 001087 (2009) |
Shufang Fan [République populaire de Chine] ; Yuwei Gao ; Kyoko Shinya ; Chris Kafai Li ; Yanbing Li ; Jianzhong Shi ; Yongping Jiang ; Yongbing Suo ; Tiegang Tong ; Gongxun Zhong ; Jiasheng Song ; Ying Zhang ; Guobin Tian ; Yuntao Guan ; Xiao-Ning Xu ; Zhigao Bu ; Yoshihiro Kawaoka [États-Unis] ; Hualan Chen | Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. |
| 001256 (2008) |
Zhongying Chen ; Celia Santos ; Amy Aspelund ; Laura Gillim-Ross ; Hong Jin ; George Kemble ; Kanta Subbarao | Evaluation of Live Attenuated Influenza A Virus H6 Vaccines in Mice and Ferrets▿ |
| 001283 (2008) |
Tomy Joseph [États-Unis] ; Josephine Mcauliffe ; Bin Lu ; Leatrice Vogel ; David Swayne ; Hong Jin ; George Kemble ; Kanta Subbarao | A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets. |
| 001476 (2006) |
Amorsolo L. Suguitan [États-Unis] ; Josephine Mcauliffe [États-Unis] ; Kimberly L. Mills [États-Unis] ; Hong Jin [États-Unis] ; Greg Duke [États-Unis] ; Bin Lu [États-Unis] ; Catherine J. Luke [États-Unis] ; Brian Murphy [États-Unis] ; David E. Swayne [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | Live, Attenuated Influenza A H5N1 Candidate Vaccines Provide Broad Cross-Protection in Mice and Ferrets |
| 002D78 (????) |
Iu A. Desheva ; G V Danini ; E P Grigor'Eva ; S A Donina ; I V Kiseleva ; A R Rekstin ; L A Ermakova ; V K Natsina ; V M Nikolaeva ; N I Lonskaia ; G A El'Shina ; V G Zhavoronkov ; V P Drinevski ; M K Erofeeva ; A N Na Khin ; L G Rudenko | [The investigation of the safety, genetic stability and immunogenicity of live influenza vaccine for adults in vaccination of 3-6 years old children]. |
| 000019 (2020) |
Andrew Smith [États-Unis] ; Laura Rodriguez [États-Unis] ; Maya El Ghouayel [États-Unis] ; Aitor Nogales [États-Unis] ; Jeffrey M. Chamberlain [États-Unis] ; Katherine Sortino [États-Unis] ; Emma Reilly [États-Unis] ; Changyong Feng [États-Unis] ; David J. Topham [États-Unis] ; Luis Martínez-Sobrido [États-Unis] ; Stephen Dewhurst [États-Unis] | A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus |
| 000102 (2019) |
Laura Rodriguez ; Pilar Blanco-Lobo ; Emma C. Reilly [États-Unis] ; Tatsuya Maehigashi ; Aitor Nogales ; Andrew Smith [États-Unis] ; David J. Topham [États-Unis] ; Stephen Dewhurst ; Baek Kim [Corée du Sud] ; Luis Martínez-Sobrido | Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines |
| 000176 (2018) |
Svetlana Shcherbik [États-Unis] ; Paul Carney [États-Unis] ; Nicholas Pearce [États-Unis] ; James Stevens [États-Unis] ; Vivien G. Dugan [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis] | Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines |
| 000178 (2018) |
D. Korenkov [Russie, Australie] ; T. H. O. Nguyen [Australie] ; I. Isakova-Sivak [Russie] ; T. Smolonogina [Russie] ; L. E. Brown [Australie] ; K. Kedzierska [Australie] ; L. Rudenko [Russie] | Live Attenuated Influenza Vaccines engineered to express the nucleoprotein of a recent isolate stimulate human influenza CD8+ T cells more relevant to current infections |
| 000264 (2017) |
Nicholas Wohlgemuth [États-Unis] ; Yang Ye [États-Unis] ; Katherine J. Fenstermacher [États-Unis] ; Hsuan Liu [États-Unis] ; Andrew P. Lane [États-Unis] ; Andrew Pekosz [États-Unis] | The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells. |
| 000294 (2017) |
Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie] | Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza. |
| 000439 (2016) |
Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie] ; Xiyan Xu [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis] | Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses. |
| 000482 (2015-11-30) |
Odile Launay [France] ; Vered Abitbol [France] ; Anne Krivine ; Lilia Ben Slama [France] ; Arnaud Bourreille [France] ; Jean Louis Dupas [France] ; Xavier Hébuterne [France] ; Guillaume Savoye [France] ; Dominique Deplanque [France] ; Yoram Bouhnik [France] ; Anne Laure Pelletier [France] ; Florence Galtier [France] ; David Laharie [France] ; Maria Nachury ; Frank Zerbib [France] ; Mathieu Allez [France] ; Gilles Bommelaer [France] ; Bernard Duclos [France] ; Frederic Lucht [France] ; Marie-Lise Gougeon [France] ; Eric Tartour [France] ; Flore Rozenberg [France] ; Thomas Hanslik [France] ; Laurent Beaugerie [France] ; Fabrice Carrat [France] | Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study. |
| 000533 (2015) |
Larisa Rudenko [Russie] ; Irina Isakova-Sivak | Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus. |
| 000556 (2015) |
Xiaolan Yang [République populaire de Chine] ; Jianyu Zhao [République populaire de Chine] ; Cheng Wang [République populaire de Chine] ; Yueqiang Duan [République populaire de Chine] ; Zhongpeng Zhao [République populaire de Chine] ; Rui Chen [République populaire de Chine] ; Liangyan Zhang [République populaire de Chine] ; Li Xing [République populaire de Chine] ; Chengcai Lai [République populaire de Chine] ; Shaogeng Zhang [République populaire de Chine] ; Xiliang Wang [République populaire de Chine] ; Penghui Yang [République populaire de Chine] | Immunization with a live attenuated H7N9 influenza vaccine protects mice against lethal challenge. |
| 000561 (2015) |
Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers |
| 000563 (2015) |
Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie] | Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses. |
| 000566 (2015) |
Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Amanda Balish [États-Unis] ; Joyce Jones [États-Unis] ; Sharmi Thor [États-Unis] ; Charles Todd Davis [États-Unis] ; Melissa Pearce [États-Unis] ; Terrence Tumpey [États-Unis] ; David Cureton [États-Unis] ; Li-Mei Chen [États-Unis] ; Julie Villanueva [États-Unis] ; Tatiana L. Bousse [États-Unis] | Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation. |
| 000599 (2015) |
Huihui Kong [République populaire de Chine] ; Qianyi Zhang [République populaire de Chine] ; Chunyang Gu [République populaire de Chine] ; Jianzhong Shi [République populaire de Chine] ; Guohua Deng [République populaire de Chine] ; Shujie Ma [République populaire de Chine] ; Jinxiong Liu [République populaire de Chine] ; Pucheng Chen [République populaire de Chine] ; Yuntao Guan [République populaire de Chine] ; Yongping Jiang [République populaire de Chine] ; Hualan Chen [République populaire de Chine] | A live attenuated vaccine prevents replication and transmission of H7N9 virus in mammals. |
| 000652 (2014) |
Christopher D. O'Donnell [États-Unis] ; Leatrice Vogel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [Indonésie] | The matrix gene segment destabilizes the acid and thermal stability of the hemagglutinin of pandemic live attenuated influenza virus vaccines. |
| 000661 (2014) |
Junwei Li ; Maria T. Arévalo ; Yanping Chen ; Shan Chen ; Mingtao Zeng | T-cell-mediated cross-strain protective immunity elicited by prime–boost vaccination with a live attenuated influenza vaccine |
| 000674 (2014) |
Andrew J. Broadbent [États-Unis] ; Celia P. Santos [États-Unis] ; Myeisha Paskel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; Janine Lu [États-Unis] ; Zhongying Chen [États-Unis] ; Hong Jin [États-Unis] ; Kanta Subbarao [États-Unis] | Replication of live attenuated cold-adapted H2N2 influenza virus vaccine candidates in non human primates |
| 000682 (2014) |
Svetlana V. Shcherbik [États-Unis] ; Nicholas C. Pearce [États-Unis] ; Marnie L. Levine [États-Unis] ; Alexander I. Klimov [États-Unis] ; Julie M. Villanueva [États-Unis] ; Tatiana L. Bousse [États-Unis] | Rapid strategy for screening by pyrosequencing of influenza virus reassortants--candidates for live attenuated vaccines. |
| 000691 (2014) |
Gerald Aichinger [Autriche] ; Barbara Grohmann-Izay [Autriche] ; Maikel V. W. Van Der Velden [Autriche] ; Sandor Fritsch [Autriche] ; Manuela Koska [Autriche] ; Daniel Portsmouth [Autriche] ; Mary Kate Hart [États-Unis] ; Wael El-Amin [États-Unis] ; Otfried Kistner [Autriche] ; P. Noel Barrett [Autriche] | Phase I/II Randomized Double-Blind Study of the Safety and Immunogenicity of a Nonadjuvanted Vero Cell Culture-Derived Whole-Virus H9N2 Influenza Vaccine in Healthy Adults |
| 000699 (2014) |
Andrey Rekstin [Russie] ; Yulia Desheva [Russie] ; Irina Kiseleva [Russie] ; Ted Ross [États-Unis] ; David Swayne [États-Unis] ; Larisa Rudenko [Russie] | Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models. |
| 000747 (2014) |
Svetlana Shcherbik [États-Unis] ; Sheila B. Sergent ; William G. Davis ; Bo Shu ; John Barnes ; Irina Kiseleva ; Natalie Larionova ; Alexander Klimov ; Tatiana Bousse | Application of real time RT-PCR for the genetic homogeneity and stability tests of the seed candidates for live attenuated influenza vaccine production. |
| 000A68 (2012) |
Dan Zheng ; Yinglei Yi ; Ze Chen [République populaire de Chine] | Development of Live-Attenuated Influenza Vaccines against Outbreaks of H5N1 Influenza |
| 000A85 (2012) |
Kawsar R. Talaat ; Ruth A. Karron ; Philana H. Liang ; Bridget A. Mcmahon ; Catherine J. Luke ; Bhagvanji Thumar ; Grace L. Chen ; Ji-Young Min ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; George W. Kemble ; Kanta Subbarao | An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults |
| 000B71 (2011-07-01) |
Odile Launay [France] ; Corinne Desaint [France] ; Christine Durier [France] ; Pierre Loulergue [France] ; Xavier Duval [France] ; Christine Jacomet [France] ; Gilles Pialoux ; Jade Ghosn [France] ; François Raffi [France] ; David Rey ; Faiza Ajana ; Nathalie Colin De Verdière [France] ; Jacques Reynes [France] ; Valérie Foubert [France] ; François Roman ; Jeanne-Marie Devaster ; Jean-François Delfraissy [France] ; Jean-Pierre Aboulker [France] ; Christian Michelet [France] | Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. |
| 000B91 (2011) |
I V Kiseleva ; J T M. Voeten ; L C P. Teley ; N V Larionova ; I A Dubrovina ; Zh A. Berdygulova ; E A Bazhenova ; H. Van Den Bosch ; J G M. Heldens ; L G Rudenko | [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine]. |
| 000C35 (2011) |
T V Chirkova [Russie] ; A N Naykhin ; G D Petukhova ; D A Korenkov ; S A Donina ; A N Mironov ; L G Rudenko | Memory T-cell immune response in healthy young adults vaccinated with live attenuated influenza A (H5N2) vaccine. |
| 000C38 (2011) |
Larisa Rudenko [Russie] ; Han Van Den Bosch ; Irina Kiseleva ; Alexander Mironov ; Anatoly Naikhin ; Natalie Larionova ; Dimitry Bushmenkov | Live attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries. |
| 000C60 (2011) |
Irina Isakova-Sivak [États-Unis] ; Li-Mei Chen ; Yumiko Matsuoka ; J Theo M. Voeten ; Irina Kiseleva ; Jacco G M. Heldens ; Han Van Den Bosch ; Alexander Klimov ; Larisa Rudenko ; Nancy J. Cox ; Ruben O. Donis | Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2). |
| 000C97 (2011) |
Rong Hai ; Adolfo García-Sastre [États-Unis] ; David E. Swayne [États-Unis] ; Peter Palese [États-Unis] | A Reassortment-Incompetent Live Attenuated Influenza Virus Vaccine for Protection against Pandemic Virus Strains▿ |
| 000D62 (2011) |
Larisa Rudenko [Russie, Australie] ; Han Van Den Bosch [Pays-Bas] ; Irina Kiseleva [Russie, Australie] ; Alexander Mironov [Russie] ; Anatoly Naikhin [Russie] ; Natalie Larionova [Russie] ; Dimitry Bushmenkov [Russie] | Live attenuated pandemic influenza vaccine: Clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries |
| 000E10 (2010) |
Yuk-Fai Lau ; Celia Santos ; Fernando J. Torres-Vélez ; Kanta Subbarao | The Magnitude of Local Immunity in the Lungs of Mice Induced by Live Attenuated Influenza Vaccines Is Determined by Local Viral Replication and Induction of Cytokines▿ † |
| 000E81 (2010) |
Zhongying Chen [États-Unis] ; Weijia Wang ; Helen Zhou ; Amorsolo L. Suguitan ; Cindy Shambaugh ; Lomi Kim ; Jackie Zhao ; George Kemble ; Hong Jin | Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. |
| 000F05 (2010) |
Alicia Sol Rzano [États-Unis] ; Jianqiang Ye [États-Unis] ; Daniel R. Pérez [États-Unis] | Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu▿ |
| 000F44 (2010) |
J. Theo M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Pays-Bas, Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] | Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model |
| 000F88 (2010) |
J. Theo [Pays-Bas] ; M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] | Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model |
| 000F90 (2010) |
ZHONGYING CHEN [États-Unis] ; WEIJIA WANG [États-Unis] ; HELEN ZHOU [États-Unis] ; Amorsolo L. Jr Suguitan [États-Unis] ; Cindy Shambaugh [États-Unis] ; Lomi Kim [États-Unis] ; Jackie Zhao [États-Unis] ; George Kemble [États-Unis] ; HONG JIN [États-Unis] | Generation of Live Attenuated Novel Influenza Virus A/California/7/09 (H1N1) Vaccines with High Yield in Embryonated Chicken Eggs |
| 000F92 (2010) |
Alicia Solorzano [États-Unis] ; JIANQIANG YE [États-Unis] ; Daniel R. Perez [États-Unis] | Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu |
| 001044 (2009) |
Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Hong Jin [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | Safety, Immunogencity and Efficacy of a Cold-Adapted A/Ann Arbor/6/60 (H2N2) Vaccine in Mice and Ferrets |
| 001132 (2009) |
Kawsar R. Talaat [États-Unis] ; Ruth A. Karron ; Karen A. Callahan ; Catherine J. Luke ; Susan C. Dilorenzo ; Grace L. Chen ; Elaine W. Lamirande ; Hong Jin ; Kathy L. Coelingh ; Brian R. Murphy ; George Kemble ; Kanta Subbarao | A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. |
| 001203 (2009) |
Kawsar R. Talaat [États-Unis] ; Ruth A. Karron [États-Unis] ; Karen A. Callahan [États-Unis] ; Catherine J. Luke [États-Unis] ; Susan C. Dilorenzo [États-Unis] ; Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; HONG JIN [États-Unis] ; Kathy L. Coelingh [États-Unis] ; Brian R. Murphy [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults |
| 001332 (2008) |
Beixing Liu [Japon, République populaire de Chine] ; Md. Jaber Hossain [Japon] ; Isamu Mori [Japon] ; Yoshinobu Kimura [Japon] | Evaluation of a virus derived from MDCK cells infected persistently with influenza A virus as a potential live‐attenuated vaccine candidate in the mouse model |
| 001361 (2007) |
Robert B. Couch [États-Unis] ; Patricia Winokur [États-Unis] ; Rebecca Brady [États-Unis] ; Robert Belshe [États-Unis] ; Wilbur H. Chen [États-Unis] ; Thomas R. Cate [États-Unis] ; Bryndis Sigurdardottir [États-Unis] ; Amy Hoeper [États-Unis] ; Irene L. Graham [États-Unis] ; Robert Edelman [États-Unis] ; Fenhua He [États-Unis] ; Diane Nino [États-Unis] ; Jose Capellan [États-Unis] ; Frederick L. Ruben [États-Unis] | Safety and Immunogenicity of a High Dosage Trivalent Influenza Vaccine among Elderly Subjects |
| 001569 (2006) |
J. A. Desheva [Russie] ; X. H. Lu [États-Unis] ; A. R. Rekstin [Russie] ; L. G. Rudenko [Russie] ; D. E. Swayne [États-Unis] ; N. J. Cox [États-Unis] ; J. M. Katz [États-Unis] ; A. I. Klimov [États-Unis] | Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential |
| 001868 (2001) |
M. D Wareing [Australie] ; G. A Tannock [Australie] | Live attenuated vaccines against influenza; an historical review |
| 001885 (2001) |
Michael Pfleiderer [Allemagne] ; Johannes Löwer [Allemagne] ; Reinhard Kurth [Allemagne] | Cold-attenuated live influenza vaccines, a risk-benefit assessment |
| 001936 (2000) |
T. G. Boyce [États-Unis] ; G. A. Poland [États-Unis] | Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review |
| 001A09 (1999) |
Hunein F. Maassab [États-Unis] ; Martin L. Bryant [États-Unis] | The development of live attenuated cold‐adapted influenza virus vaccine for humans |
| 001A18 (1999) |
H. F. Maassab [États-Unis] | Principle of cold-adaptation in the derivation of live attenuated respiratory virus vaccines |
| 001B88 (1997) |
Alan P. Kendal [États-Unis] | Cold-adapted live attenuated influenza vaccines developed in Russia: Can they contribute to meeting the needs for influenza control in other countries? |
| 002250 (1988) |
Nancy J. Cox [États-Unis] ; Fumio Kitame [Japon] ; Alan P. Kendal [États-Unis] ; Hunein F. Maassab [États-Unis] ; Clayton Naeve [États-Unis] | Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2) |
| 002469 (1985) |
Philip R. Johnson Jr. [États-Unis] ; Sandor Feldman ; Juliette M. Thompson ; Josephine D. Mahoney ; Peter F. Wright | Comparison of long‐term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine |
| 002552 (1984) |
R. B. Belshe ; L. P. Van Voris ; J. Bartram ; F. K. Crookshanks | Live attenuated influenza A virus vaccines in children: results of a field trial |
| 002B01 (1976) |
J M Gwaltney | The use of live attenuated influenza vaccine ts-1(E) in man. |
| 002D84 (????) |
E P Grigor'Eva ; Iu A. Desheva ; S A Donina ; A N Na Khin ; A R Rekstin ; I B Barantseva ; E A Zavitkova ; T M Moskvicheva ; V G Zhavoronkov ; L G Rudenko | [The comparative characteristics of the safety, immunogenic activity and prophylactic potency of the adult and children types of live influenza vaccine in schoolchildren aged 7-14 years]. |
| 002E13 (????) |
M V Sergeeva ; V V Kuznetsov ; M A Kas'Ianenko ; A A Shaldzhian ; I A Repko ; M V Potapchuk ; Iu R. Romanova ; L M Tsybalova | [Immunization with live attenuated A/H5N1 vaccine protects guinea pigs from reinfection]. |
| 002E38 (????) |
O S Kashirina ; M I Chernikova ; Yu M. Vasiliev | [COMPARATIVE STUDY OF IMMUNOGENICITY AND PROTECTIVE EFFECT OF LIVE COLD-ADAPTED AND INACTIVATED VACCINES AGAINST TYPE A INFLUENZA]. |
| 002E48 (????) |
H F Maassab [États-Unis] ; M L Bryant | The development of live attenuated cold-adapted influenza virus vaccine for humans. |
| 000059 (2019) |
Danuta M. Skowronski [Canada] ; Suzana Sabaiduc [Canada] ; Siobhan Leir [Canada] ; Caren Rose [Canada] ; Macy Zou [Canada] ; Michelle Murti [Canada] ; James A. Dickinson [Canada] ; Romy Olsha [Canada] ; Jonathan B. Gubbay [Canada] ; Matthew A. Croxen [Canada] ; Hugues Charest [Canada] ; Nathalie Bastien [Canada] ; Yan Li [Canada] ; Agatha Jassem [Canada] ; Mel Krajden [Canada] ; Gaston De Serres [Canada] | Paradoxical clade- and age-specific vaccine effectiveness during the 2018/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV) |
| 000070 (2019) |
Esther Kissling [France] ; Francisco Pozo [Espagne] ; Silke Buda [Allemagne] ; Ana-Maria Vilcu [France] ; Alin Gherasim [Espagne] ; Mia Brytting [Suède] ; Lisa Domegan [Irlande (pays), Suède] ; Ver Nica G Mez [Portugal] ; Adam Meijer [Pays-Bas] ; Mihaela Lazar [Roumanie] ; Vesna Višekruna Vu Ina [Croatie] ; Ralf Dürrwald [Allemagne] ; Sylvie Van Der Werf [France] ; Amparo Larrauri [Espagne] ; Theresa Enkirch [Suède] ; Joan O Onnell [Irlande (pays)] ; Raquel Guiomar [Portugal] ; Mariëtte Hooiveld [Pays-Bas] ; Goranka Petrovi [Croatie] ; Elena Stoian [Roumanie] ; Pasi Penttinen [Suède] ; Marta Valenciano [France] | Low 2018/19 vaccine effectiveness against influenza A(H3N2) among 15–64-year-olds in Europe: exploration by birth cohort |
| 000126 (2018-03) |
Marc Rondy [France] ; Esther Kissling [France] ; Hanne-Dorthe Emborg [Danemark] ; Alin Gherasim ; Richard Pebody ; Ramona Trebbien ; Francisco Pozo ; Amparo Larrauri ; Jim Mcmenamin ; Marta Valenciano [France] ; I-Move I-Move Group ; Vincent Foulongne [France] | Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies |
| 000136 (2018) |
Esther Kissling [France] ; Marta Valenciano [France] ; Francisco Pozo [Espagne] ; Ana-Maria Vilcu [France] ; Annicka Reuss [Allemagne] ; Caterina Rizzo [Italie] ; Amparo Larrauri [Espagne] ; Judit Krisztina Horváth [Hongrie] ; Mia Brytting [Suède] ; Lisa Domegan [Irlande (pays)] ; Monika Korczy Ska [Pologne] ; Adam Meijer [Pays-Bas] ; Ausenda Machado [Portugal] ; Alina Ivanciuc [Roumanie] ; Vesna Višekruna Vu Ina [Croatie] ; Sylvie Van Der Werf [France] ; Brunhilde Schweiger [Allemagne] ; Antonino Bella [Italie] ; Alin Gherasim [Espagne] ; Annamária Ferenczi [Hongrie] ; Katherina Zakikhany [Suède] ; Joan O Onnell [Irlande (pays)] ; Iwona Paradowska-Stankiewicz [Pologne] ; Frederika Dijkstra [Pays-Bas] ; Raquel Guiomar [Portugal] ; Mihaela Lazar [Roumanie] ; Sanja Kure I Filipovi [Croatie] ; Kari Johansen [Suède] ; Alain Moren [France] | 2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children |
| 000188 (2018) |
Brendan Flannery [Géorgie (pays)] ; Catherine Smith [Géorgie (pays)] ; Rebecca J. Garten [Géorgie (pays)] ; Min Z. Levine [Géorgie (pays)] ; Jessie R. Chung [Géorgie (pays)] ; Michael L. Jackson [États-Unis] ; Lisa A. Jackson [États-Unis] ; Arnold S. Monto ; Emily T. Martin ; Edward A. Belongia [États-Unis] ; Huong Q. Mclean [États-Unis] ; Manjusha Gaglani ; Kempapura Murthy ; Richard Zimmerman [États-Unis] ; Mary Patricia Nowalk [États-Unis] ; Marie R. Griffin [États-Unis] ; H. Keipp Talbot [États-Unis] ; John J. Treanor [États-Unis] ; David E. Wentworth [Géorgie (pays)] ; Alicia M. Fry [Géorgie (pays)] | Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States |
| 000192 (2018) |
Joseph A. Lewnard ; Sarah Cobey [États-Unis] | Immune History and Influenza Vaccine Effectiveness |
| 000236 (2017-12) |
Nitin Machindra Kamble ; Kim Je Hyoung ; John Hwa Lee | Intracellular delivery of HA1 subunit antigen through attenuated Salmonella Gallinarum act as a bivalent vaccine against fowl typhoid and low pathogenic H5N3 virus |
| 000242 (2017-10) |
Cécile Souty [France] ; Ana-Maria Vilcu [France] ; Lisandru Capai [France] ; Sylvie Van Der Werf [France] ; Martine Valette [France] ; Thierry Blanchon [France] ; Bruno Lina [France] ; Sylvie Behillil [France] ; Thomas Hanslik [France] ; Alessandra Falchi [France] | Early estimates of 2016/17 seasonal influenza vaccine effectiveness in primary care in France |
| 000243 (2017-09-28) |
Marc Rondy [France] | Post authorisation influenza vaccine effectiveness against influenza associated hospitalisation with laboratory confirmed influenza among adults in Europe |
| 000246 (2017-07-27) |
Marc Rondy [France] ; Amparo Larrauri [Espagne] ; Itziar Casado [Espagne] ; Valeria Alfonsi [Italie] ; Daniela Pitigoi [Roumanie] ; Odile Launay [France] ; Ritva Syrj Nen ; Giedre Gefenaite ; Ausenda Machado [Portugal] ; Vesna Višekruna Vu Ina ; Judith Krisztina Horváth [Hongrie] ; Iwona Paradowska-Stankiewicz ; Sierk Marbus [Pays-Bas] ; Alin Gherasim [Espagne] ; Jorge Alberto Díaz-González ; Caterina Rizzo [Italie] ; Alin Ivanciuc ; Florence Galtier [France] ; Niina Ikonen [Finlande] ; Aukse Mickiene [Lituanie] ; Ver Nica Gomez [Portugal] ; Sanja Kure I Filipovi ; Annamária Ferenczi [Hongrie] ; Monika Korcinska ; Rianne Van Gageldonk-Lafeber [Pays-Bas] ; Marta Valenciano [France] | 2015/16 seasonal vaccine effectiveness against hospitalisation with influenza A(H1N1)pdm09 and B among elderly people in Europe: results from the I-MOVE+ project |
| 000252 (2017) |
Marc Rondy [France] ; Alin Gherasim [Espagne] ; Itziar Casado [Espagne] ; Odile Launay [France] ; Caterina Rizzo [France] ; Daniela Pitigoi [Roumanie] ; Aukse Mickiene [Lituanie] ; Sierk D. Marbus [Pays-Bas] ; Ausenda Machado [Portugal] ; Ritva K. Syrj Nen [Finlande] ; Iva Pem-Novose [Croatie] ; Judith Krisztina Horváth [Hongrie] ; Amparo Larrauri [Espagne] ; Jesus Castilla [Espagne] ; Philippe Vanhems [France] ; Valeria Alfonsi [France] ; Alina E. Ivanciuc [Roumanie] ; Monika Kuliese [Lituanie] ; Rianne Van Gageldonk-Lafeber [Pays-Bas] ; Ver Nica Gomez [Portugal] ; Niina Ikonen [Finlande] ; Zvjezdana Lovric [Croatie] ; Annamária Ferenczi [Hongrie] ; Alain Moren [France] | Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season |
| 000339 (2017) |
Danuta M. Skowronski ; Catharine Chambers ; Suzana Sabaiduc ; Gaston De Serres ; Anne-Luise Winter ; James A. Dickinson [Canada] ; Jonathan B. Gubbay [Canada] ; Steven J. Drews ; Christine Martineau ; Hugues Charest ; Mel Krajden ; Nathalie Bastien [Canada] ; Yan Li [Canada] | Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada |
| 000356 (2016-12-23) |
Guillermo Ruiz-Palacios [Mexique] ; Geert Leroux-Roels [Belgique] ; Jiri Beran [République tchèque] ; Jeanne-Marie Devaster [Belgique] ; Meral Esen [Allemagne] ; Odile Launay [France] ; Janet Mcelhaney [Canada] ; Gerrit Van Essen [Pays-Bas] ; Anne Benoit [Belgique] ; Carine Claeys [Belgique] ; Walthère Dewé [Belgique] ; Christelle Durand [Belgique] ; Xavier Duval [France] ; Ann Falsey [États-Unis] ; Gregory Feldman [États-Unis] ; Florence Galtier [France] ; Pierre Gervais [France] ; Shinn-Jang Hwang [Taïwan] ; Shelly Mcneil [Canada] ; Jan Hendrik Richardus [Pays-Bas] ; Andrew Trofa [États-Unis] ; Lidia Oostvogels [Belgique] | Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis |
| 000383 (2016-02-02) |
M. Rondy ; J. Castilla ; O. Launay [France] ; S. Costanzo ; C. Ezpeleta ; F. Galtier [France] ; K. Gaetano Donati | Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network |
| 000445 (2016) |
I. Barberis [Italie] ; P. Myles [Royaume-Uni] ; S. K. Ault [États-Unis] ; N. L. Bragazzi [Italie] ; M. Martini [Italie] | History and evolution of influenza control
through vaccination: from the first monovalent vaccine
to universal vaccines |
| 000490 (2015-01-15) |
M. Rondy [France] ; O. Launay [France] ; J. Puig-Barberà ; G. Gefenaite ; J. Castilla ; K. De Gaetano Donati ; F. Galtier [France] ; E. Hak ; M. Guevara ; S. Costanzo ; A. Moren [France] | 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals. |
